Raras
Buscar doenças, sintomas, genes...
Síndrome de imunodesregulação-poliendocrinopatia-enteropatia ligada ao X
ORPHA:37042CID-10 · E31.0CID-11 · 4A01.21OMIM 304790DOENÇA RARA

A síndrome de imunodisregulação - poliendocrinopatia - enteropatia - ligada ao X (IPEX) é uma doença autoimune sistêmica congênita grave caracterizada por diarreia refratária, endocrinopatias, envolvimento cutâneo e infecções.

Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

📋

A síndrome de imunodisregulação - poliendocrinopatia - enteropatia - ligada ao X (IPEX) é uma doença autoimune sistêmica congênita grave caracterizada por diarreia refratária, endocrinopatias, envolvimento cutâneo e infecções.

Pesquisas ativas
2 ensaios
6 total registrados no ClinicalTrials.gov
Publicações científicas
77 artigos
Último publicado: 2026 Jan

Escala de raridade

CLASSIFICAÇÃO ORPHANET · BRASIL 2024
<1 / 1 000 000
Ultra-rara
<1/50k
Muito rara
1/20k
Rara
1/10k
Pouco freq.
1/5k
Incomum
1/2k
Prevalência
0.0
Worldwide
Casos conhecidos
195
pacientes catalogados
Início
Infancy
+ neonatal
🏥
SUS: Sem cobertura SUSScore: 0%
CID-10: E31.0
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Partes do corpo afetadas

🩸
Sangue
11 sintomas
📏
Crescimento
11 sintomas
🫃
Digestivo
9 sintomas
🧬
Pele e cabelo
7 sintomas
🛡️
Imunológico
4 sintomas
🫘
Rins
4 sintomas

+ 24 sintomas em outras categorias

Características mais comuns

100%prev.
Diarreia crônica
Frequência: 28/28
92%prev.
Aumento do nível circulante de IgE
Frequente (79-30%)
90%prev.
Autoimunidade
Muito frequente (99-80%)
84%prev.
Dermatite eczematoide
Frequente (79-30%)
75%prev.
Déficit de crescimento
Frequência: 66/88
55%prev.
Tireoidite
Frequente (79-30%)
79sintomas
Muito frequente (4)
Frequente (19)
Ocasional (37)
Muito raro (14)
Sem dados (5)

Os sintomas variam de pessoa para pessoa. Abaixo estão as 79 características clínicas mais associadas, ordenadas por frequência.

Diarreia crônicaChronic diarrhea
Frequência: 28/28100%
Aumento do nível circulante de IgEIncreased circulating IgE level
Frequente (79-30%)92%
AutoimunidadeAutoimmunity
Muito frequente (99-80%)90%
Dermatite eczematoideEczematoid dermatitis
Frequente (79-30%)84%
Déficit de crescimentoFailure to thrive
Frequência: 66/8875%

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa1desde 2025
Total histórico77PubMed
Últimos 10 anos128publicações
Pico202117 papers
Linha do tempo
2025Hoje · 2026🧪 2009Primeiro ensaio clínico📈 2021Ano de pico
Publicações por ano (últimos 10 anos)

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

Genes associados

1 gene identificado com associação a esta condição. Padrão de herança: X-linked recessive.

FOXP3Forkhead box protein P3Disease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Transcriptional regulator which is crucial for the development and inhibitory function of regulatory T-cells (Treg) (PubMed:17377532, PubMed:21458306, PubMed:23947341, PubMed:24354325, PubMed:24722479, PubMed:24835996, PubMed:30513302, PubMed:32644293). Plays an essential role in maintaining homeostasis of the immune system by allowing the acquisition of full suppressive function and stability of the Treg lineage, and by directly modulating the expansion and function of conventional T-cells (Pub

LOCALIZAÇÃO

NucleusCytoplasm

VIAS BIOLÓGICAS (2)
RUNX1 regulates transcription of genes involved in WNT signalingRUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs)
MECANISMO DE DOENÇA

Immunodeficiency polyendocrinopathy, enteropathy, X-linked syndrome

Characterized by neonatal onset insulin-dependent diabetes mellitus, infections, secretory diarrhea, thrombocytopenia, anemia and eczema. It is usually lethal in infancy.

EXPRESSÃO TECIDUAL(Baixa expressão)
Testículo
2.8 TPM
Baço
2.7 TPM
Sangue
2.0 TPM
Skin Sun Exposed Lower leg
1.9 TPM
Skin Not Sun Exposed Suprapubic
1.9 TPM
OUTRAS DOENÇAS (1)
immune dysregulation-polyendocrinopathy-enteropathy-X-linked syndrome
HGNC:6106UniProt:Q9BZS1

Variantes genéticas (ClinVar)

236 variantes patogênicas registradas no ClinVar.

🧬 FOXP3: NM_014009.4(FOXP3):c.766A>G (p.Met256Val) ()
🧬 FOXP3: NM_014009.4(FOXP3):c.711_712del (p.Glu237fs) ()
🧬 FOXP3: NM_014009.4(FOXP3):c.646_647+2del ()
🧬 FOXP3: NM_014009.4(FOXP3):c.816+5G>A ()
🧬 FOXP3: NM_014009.4(FOXP3):c.816+7G>C ()
Ver todas no ClinVar

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Pipeline de tratamentos
Pipeline regulatório — de medicamentos já aprovados a drogas em pesquisa exploratória.
2Fase 21
1Fase 11
Medicamentos catalogadosEnsaios clínicos· 0 medicamentos · 2 ensaios
Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Síndrome de imunodesregulação-poliendocrinopatia-enteropatia ligada ao X

🗺️

Selecione um estado ou use sua localização para ver resultados.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

🟢 Recrutando agora

2 pesquisas recrutando participantes. Converse com seu médico sobre a possibilidade de participar.

Outros ensaios clínicos

🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Publicações mais relevantes

Timeline de publicações
43 papers (10 anos)
#1

Pediatric IPEX-Associated Dermatitis Responds To Dupilumab: Evidence from Skin Transcriptomics and Immune Profiling.

Journal of clinical immunology2026 Feb 07

Immunodysregulation, Polyendocrinopathy, Enteropathy, and X-linked (IPEX) syndrome is a rare autoimmune disorder caused by mutations in the FOXP3 gene. Patients with IPEX frequently present with severe dermatitis, diabetes, and enteropathy. This study explores the efficacy of Dupilumab (an anti-IL-4Rα monoclonal antibody) in treating persistent, severe dermatitis in an IPEX patient refractory to conventional treatments like sirolimus. We conducted a clinical case study of a 2-year-old IPEX patient with refractory dermatitis. Whole-exome sequencing (WES) confirmed the FOXP3 mutation. Skin biopsies were analyzed for inflammatory gene expression by RNA sequencing and immunohistochemistry to characterize inflammatory pathways. Immune cell phenotyping was performed using flow cytometry pre- and post-treatment in peripheral blood mononuclear cells (PBMCs). The patient was treated with Dupilumab alongside sirolimus and prednisone. Clinical improvements were evaluated using the Eczema Area and Severity Index (EASI) score. Immunohistochemistry revealed elevated IL-13 expression. RNA sequencing of skin samples revealed upregulation of both Th1- and Th2-related genes, suggesting a dual inflammatory phenotype in IPEX dermatitis. The patient exhibited significant clinical improvement after 8 months of sustained Dupilumab therapy, with the EASI decreasing from 24.8 to 0.4. Flow cytometry demonstrated a reduction in Th1 and Th2 cell subsets post-treatment, accompanied by an increase in Treg and Th3 cell populations as well as enhanced expression of immunosuppressive markers such as CTLA-4 and CD39. Dupilumab appears promising as a therapeutic option for managing refractory dermatitis in IPEX, particularly by attenuating Th1/Th2 inflammation and promoting regulatory responses mediated by Treg and Th3 cells. Primary immunodeficiencies are a heterogeneous group of inherited disorders affecting the immune system, with more than 450 distinct genetic defects identified to date. Patients with an X-linked immunodeficiency typically present with frequent and recurrent infections alongside immune dysregulation manifesting as autoimmunity, lymphoproliferation, granuloma formation, chronic inflammatory diseases, and increased susceptibility to malignancies. Among this group of disorders, 7 major X-linked immunodeficiency disorders have been well-characterized: X-linked chronic granulomatous disease (X-CGD), X-linked hyper-IgM syndrome, X-linked lymphoproliferative syndrome (XLP), Wiskott-Aldrich syndrome (WAS), X-linked severe combined immunodeficiency (X-SCID), X-linked agammaglobulinemia (XLA), and IPEX (Immune dysregulation, Polyendocrinopathy, Enteropathy, X-linked) syndrome. These conditions result in cellular or humoral immune deficiency, leading to serious infections and increased morbidity and mortality from early life. Identifying carriers remains challenging in the absence of family history, despite advances in genetic testing.

#2

Decoding VEXAS syndrome: emerging insights into pathogenesis and clinical management.

Current opinion in rheumatology2026 Jan 01

VEXAS (Vacuoles, E1 enzyme, X-linked, Autoinflammatory, Somatic) syndrome is a newly discovered, adult-onset, hemato-inflammatory disease driven by clonal dominance of pro-inflammatory hematopoietic cells bearing a somatic mutation in the UBA1 gene. This review aims to integrate and discuss the most recent insights into the evolving understanding of VEXAS pathogenesis and clinical management. An interplay between inflammation and clonal dominance of UBA1 mutant hematopoietic clones underlies the pathogenesis of VEXAS syndrome. Mutant cells both generate and sustain a toxic inflammatory milieu that impairs wild-type hematopoiesis. Despite exhibiting dysfunctional differentiation, VEXAS cells activate pro-survival pathways that support their persistence and progressive dominance.Recent international guidelines offer evidence-based recommendations to optimize therapy and manage both inflammatory and hematologic features of the disease. This review dissects the key molecular mechanisms driving inflammation and clonal survival in UBA1 mutant cells, and outlines current therapeutic strategies proposed to counteract VEXAS progression and improve patient outcomes. The recent findings presented here, along with the deeper understanding that will be built upon them, not only advance the knowledge of the disease pathobiology, but also pave the way for more precise, mechanism-driven treatment approaches aimed at intercepting disease progression and improving long-term outcomes.

#3

[Immuno'logical (The scientific updates you wouldn't dare to read anywhere else): The hidden face of VEXAS syndrome].

La Revue de medecine interne2026 Feb

The VEXAS syndrome, whose phenotype has been extensively described in recent years, is now beginning to unveil the secrets of its pathophysiology. For those who tend to keep a respectful distance from basic science papers, Immuno'logical offers a guided dive into two recent fascinating publications, that challenge several long-held assumptions: no, VEXAS is not merely a myeloid disorder; no, UBA1-wild-type cells are not blameless in systemic inflammation; and no, UBA1-mutated progenitors do not owe their clonal dominance to uncontrolled proliferation. To understand it all, we will decode ubiquitination, single-cell RNA-sequencing, and clonal expansion - thoroughly but without unnecessary complexity - to uncover the hidden gems within these studies. In short, let's be serious without taking ourselves too seriously, and explore the hidden side of VEXAS syndrome.

#4

Autoimmune polyendocrine syndrome type 2 in children: a case report and literature review.

BMC pediatrics2025 May 02

Autoimmune polyendocrine syndrome (APS) is a clinical disorder characterized by the loss of immune tolerance, leading to dysfunction in multiple endocrine glands. According to the latest disease classification, APS is categorized into three main subtypes: APS-1, APS-2, and IPEX (Immune Dysregulation, Polyendocrinopathy, Enteropathy, X-linked) syndrome. APS-2 is defined by the presence of at least two autoimmune endocrine disorders, such as type 1 diabetes mellitus, autoimmune thyroiditis, or Addison's disease. APS-2 typically manifests later than APS-1, with onset most commonly occurring in early adulthood. However, pediatric cases involving a combination of autoimmune thyroid disease, type 1 diabetes mellitus, and myasthenia gravis, are extremely rare. This article reported the case of a 3-year-old girl diagnosed with autoimmune polyendocrine syndrome type 2 (APS-2). The patient initially presented with hyperthyroidism and exophthalmos and was subsequently diagnosed with type 1 diabetes mellitus and myasthenia gravis. To our knowledge, this case represents the youngest reported patient of APS-2 at the time of diagnosis, as well as the shortest documented interval between the onset of autoimmune disorders affecting distinct endocrine glands. Through a retrospective analysis, we comprehensively reviewed the phenotypic characteristics of APS-2 and explored its potential immune mechanisms. This article aims to provide clinicians with a valuable reference case to enhance early recognition and facilitate the implementation of targeted prevention and treatment strategies.

#5

Neutrophils take center stage in VEXAS syndrome pathogenesis.

The Journal of clinical investigation2025 Nov 03

Vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic (VEXAS) syndrome is an adult-onset inflammatory disorder caused by somatic UBA1 mutations in hematopoietic stem cells. UBA1 encodes a key enzyme that catalyzes protein ubiquitination. Clinically, VEXAS is characterized by systemic inflammation and hematologic abnormalities. Patient studies have hinted that the transition of UBA1-mutated stem cells into proinflammatory myeloid precursors may propagate the manifestations of VEXAS syndrome. In this issue of the JCI, Dong and colleagues developed nine unique conditional knockout mouse strains and found that only neutrophil-specific Uba1 deletion reproduced VEXAS syndrome-like findings. The observed phenotype was at least in part due to inflammatory reprogramming and longer survival of the mutant neutrophils. In addition to deepening our mechanistic understanding of VEXAS syndrome pathogenesis, this work should provide a platform to pursue more targeted approaches to treatment.

Publicações recentes

Ver todas no PubMed

📚 EuropePMC45 artigos no totalmostrando 128

2026

Pediatric IPEX-Associated Dermatitis Responds To Dupilumab: Evidence from Skin Transcriptomics and Immune Profiling.

Journal of clinical immunology
2025

Neutrophils take center stage in VEXAS syndrome pathogenesis.

The Journal of clinical investigation
2026

Decoding VEXAS syndrome: emerging insights into pathogenesis and clinical management.

Current opinion in rheumatology
2025

Beyond the Classical Triad: Atypical Presentations and Regulatory T Cell Phenotyping in a Cohort of IPEX Patients.

Journal of clinical immunology
2025

Atopic dermatitis in inborn errors of immunity: at the interface of immunodeficiency and immune dysregulation.

Immunologic research
2025

Interval Changes in Hematopoietic Vacuolization in VEXAS Syndrome with M41T Mutation: Insights into Diagnosis and Disease Progression.

Clinical laboratory
2025

Cyclophosphamide post-haploidentical stem cell transplantation experience in an infant with IPEX syndrome.

Biomedica : revista del Instituto Nacional de Salud
2025

The Targets of Immune Adverse Events in Cancer Immunotherapy by Combined Check-point Inhibitors Resemble those Seen in IPEX Patients.

Journal of clinical immunology
2025

Case report: anti-IL-6 autoantibodies in a patient with immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome.

Frontiers in immunology
2026

[Immuno'logical (The scientific updates you wouldn't dare to read anywhere else): The hidden face of VEXAS syndrome].

La Revue de medecine interne
2025

From diagnostic uncertainty to targeted therapy: a case-based review of VEXAS syndrome.

Rheumatology international
2025

Clonal hematopoiesis meets an autoinflammatory disease: the new paradigm of VEXAS syndrome.

Expert review of hematology
2025

Autoimmune polyendocrine syndrome type 2 in children: a case report and literature review.

BMC pediatrics
2024

Diagnostic dilemma in infantile refractory diarrhea: a rare case of IPEX syndrome.

Medical journal, Armed Forces India
2025

VEXAS syndrome: is it more a matter of inflammation or hematopoietic clonality? A case series approach to diagnosis, therapeutic strategies and transplant management.

Annals of hematology
2024

Sirolimus alleviated intractable diarrhea of IPEX syndrome: a case report and literature review.

BMC pediatrics
2024

Expanding the spectrum of IPEX: from new clinical findings to novel treatments.

Current opinion in allergy and clinical immunology
2024

Diverse Clinical and Immunological Profiles in Patients with IPEX Syndrome: a Multicenter Analysis from Turkey.

Journal of clinical immunology
2024

HSCT in a Patient with Cernunnos/XLF Deficiency and Omenn Syndrome.

Journal of clinical immunology
2025

A rare case of late-onset immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) syndrome confused with IgA vasculitis nephropathy.

Pediatric nephrology (Berlin, Germany)
2024

A splice of life: the discovery, function, and clinical implications of FOXP3 isoforms in autoimmune disease.

International immunology
2024

IL-27 Gene Therapy Ameliorates IPEX Syndrome Caused by Germline Mutation of Foxp3 Gene: A Major Role for Induction of IL-10.

Journal of immunology (Baltimore, Md. : 1950)
2024

Effective Management of XLA Associated Enteropathy with Vedolizumab Monotherapy.

Journal of clinical immunology
2024

Salvianolic acid B alleviates autoimmunity in Treg-deficient mice via inhibiting IL2-STAT5 signaling.

Phytotherapy research : PTR
2024

Novel premature termination codon in the FOXP3 gene as the cause of familial hydrops fetalis in males.

Prenatal diagnosis
2024

[Clinical features and genetic analysis of three patients with Immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome due to variants of FOXP3 gene].

Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics
2024

IPEX syndrome from diagnosis to cure, learning along the way.

The Journal of allergy and clinical immunology
2023

A novel FOXP3 knockout-humanized mouse model for pre-clinical safety and efficacy evaluation of Treg-like cell products.

Molecular therapy. Methods &amp; clinical development
2024

FOXP3 deficiency, from the mechanisms of the disease to curative strategies.

Immunological reviews
2023

[Hematopoietic cell transplantation for monogenic inflammatory bowel disease].

[Rinsho ketsueki] The Japanese journal of clinical hematology
2023

Mutations from patients with IPEX ported to mice reveal different patterns of FoxP3 and Treg dysfunction.

Cell reports
2023

Regulatory T cells in peripheral tissue tolerance and diseases.

Frontiers in immunology
2023

A Case Report of IPEX Syndrome with Neonatal Diabetes Mellitus and Congenital Hypothyroidism as the Initial Presentation, and a Systematic Review of neonatal IPEX.

Journal of clinical immunology
2022

Case report: Dupilumab treatment improved type 2 disorders in a patient with IPEX syndrome diagnosis.

Frontiers in immunology
2023

FOXP3 TSDR Measurement Could Assist Variant Classification and Diagnosis of IPEX Syndrome.

Journal of clinical immunology
2022

Case Report: Eosinophilic gastritis with pyloric stenosis in immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome.

Frontiers in pediatrics
2022

Splicing factor SRSF1 controls autoimmune-related molecular pathways in regulatory T cells distinct from FoxP3.

Molecular immunology
2023

Immune dysregulation, polyendocrinopathy and enteropathy, X-linked (IPEX) syndrome due to a mutation in FOXP3, modified by a pathogenic variant in SON (SON DNA-binding protein).

Journal of applied genetics
2023

Epigenetic and immunological indicators of IPEX disease in subjects with FOXP3 gene mutation.

The Journal of allergy and clinical immunology
2022

Atopic Dermatitis-like Genodermatosis: Disease Diagnosis and Management.

Diagnostics (Basel, Switzerland)
2022

Clinical and immunological characteristics of five patients with immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome in China-expanding the atypical phenotypes.

Frontiers in immunology
2022

Towards gene therapy for IPEX syndrome.

European journal of immunology
2022

Identification of a novel variant of FOXP3 resulting in severe immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome highlights potential pitfalls of molecular testing.

Pediatric dermatology
2021

Protein-losing enteropathy caused by Yersinia enterocolitica colitis.

Paediatrics and international child health
2021

Anti-voltage-Gated Potassium Channel (VGKC) Antibodies and Acquired Neuromyotonia in Patients with Immune Dysregulation, Polyendocrinopathy, Enteropathy X-Lined (IPEX) Syndrome.

Journal of clinical immunology
2021

Generalized eczematous dermatitis and pruritus responsive to dupilumab in a patient with immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) syndrome.

Pediatric dermatology
2021

Myelodysplastic Syndrome in a Patient with IPEX Syndrome.

Journal of clinical immunology
2021

Immune Dysregulation, Polyendocrinopathy, Enteropathy, X-Linked Syndrome Manifesting as Lymphocytic Interstitial Pneumonia and Treatment-Resistant Bullous Pemphigoid.

Pediatric allergy, immunology, and pulmonology
2022

Immune Dysregulation, Polyendocrinopathy, Enteropathy, X-linked Syndrome in Two Siblings: Same Mutation But Different Clinical Manifestations at Onset.

Journal of clinical research in pediatric endocrinology
2022

Molecular diagnosis of childhood immune dysregulation, polyendocrinopathy, and enteropathy, and implications for clinical management.

The Journal of allergy and clinical immunology
2021

Single-cell analysis of FOXP3 deficiencies in humans and mice unmasks intrinsic and extrinsic CD4+ T cell perturbations.

Nature immunology
2021

Limosilactobacillus reuteri and Lacticaseibacillus rhamnosus GG differentially affect gut microbes and metabolites in mice with Treg deficiency.

American journal of physiology. Gastrointestinal and liver physiology
2021

A delayed diagnosis of atypical immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) syndrome: A case report.

Medicine
2021

[Clinical features and genetic analysis of a child with late-onset immune dysregulation, polyendocrinopathy, enteropathy, X-Linked syndrome].

Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics
2021

New Findings of Immunodysregulation, Polyendocrinopathy, and Enteropathy X-linked Syndrome (IPEX); Granulomas in Lung and Duodenum.

Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society
2021

IPEX Syndrome: Genetics and Treatment Options.

Genes
2021

A hemizygous mutation in the FOXP3 gene (IPEX syndrome) resulting in recurrent X-linked fetal hydrops: a case report.

BMC medical genomics
2021

Atypical late-onset severe gastritis in immune dysregulation, polyendocrinopathy, enteropathy, and X-linked (IPEX) syndrome: 2 case reports.

Medicine
2020

[New mutation in FOXP3 gene identified in an infant with chronic diarrhea as manifestation of autoinmune enteropathy - IPEX syndrome].

Revista chilena de pediatria
2021

Fecal microbiota transplantation before hematopoietic stem cell transplantation in a pediatric case of chronic diarrhea with a FOXP3 mutation.

Pediatrics and neonatology
2021

T cell gene therapy to treat immunodeficiency.

British journal of haematology
2021

Opinion and Special Articles: Cerebellar Ataxia and Liver Failure Complicating IPEX Syndrome.

Neurology
2021

Posthematopoietic stem cell transplant COVID-19 infection in a pediatric patient with IPEX syndrome.

Pediatric blood &amp; cancer
2020

IPEX Syndrome with Normal FOXP3 Protein Expression in Treg Cells in an Infant Presenting with Intractable Diarrhea as a Single Symptom.

Case reports in immunology
2020

Fungal infections in primary immunodeficiency diseases.

Clinical immunology (Orlando, Fla.)
2020

Foxp3: a genetic foundation for regulatory T cell differentiation and function.

Nature immunology
2020

Early-onset refractory diarrhea due to immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome associated with a novel mutation in the FOXP3 gene: A case report.

World journal of clinical cases
2020

In situ conversion of defective Treg into SuperTreg cells to treat advanced IPEX-like disorders in mice.

Nature communications
2020

Infliximab induces clinical resolution of sacroiliitis that coincides with increased circulating FOXP3+ T cells in a patient with IPEX syndrome.

Joint bone spine
2020

Pharmacological Inhibition of MALT1 Protease Leads to a Progressive IPEX-Like Pathology.

Frontiers in immunology
2020

Molecular feature and therapeutic perspectives of immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome.

Journal of genetics and genomics = Yi chuan xue bao
2019

Unusual and early onset IPEX syndrome: a case report.

The Turkish journal of pediatrics
2019

IPEX syndrome: an easily-missed diagnosis of a life threatening condition.

The Turkish journal of pediatrics
2020

Treatment with rapamycin can restore regulatory T-cell function in IPEX patients.

The Journal of allergy and clinical immunology
2020

Germline gain-of-function mutation of STAT1 rescued by somatic mosaicism in immune dysregulation-polyendocrinopathy-enteropathy-X-linked-like disorder.

The Journal of allergy and clinical immunology
2019

Antibiotic-modulated microbiome suppresses lethal inflammation and prolongs lifespan in Treg-deficient mice.

Microbiome
2019

Hematopoietic stem cell transplantation recovers insulin deficiency in type 1 diabetes mellitus associated with IPEX syndrome.

Pediatric diabetes
2019

[A case of immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome with very early onset inflammatory bowel disease-like changes].

Zhonghua er ke za zhi = Chinese journal of pediatrics
2019

[Erythroderma revealing IPEX syndrome].

Annales de dermatologie et de venereologie
2019

The autoimmune targets in IPEX are dominated by gut epithelial proteins.

The Journal of allergy and clinical immunology
2019

Identification of autoantibodies using human proteome microarrays in patients with IPEX syndrome.

Clinical immunology (Orlando, Fla.)
2019

The FOXP3Δ2 isoform supports Treg cell development and protects against severe IPEX syndrome.

The Journal of allergy and clinical immunology
2019

Mechanisms of human FoxP3+ Treg cell development and function in health and disease.

Clinical and experimental immunology
2019

The role of FOXP3+ regulatory T cells in human autoimmune and inflammatory diseases.

Clinical and experimental immunology
2019

Recurrent Non Immune Fetal Hydrops Associated With IPEX Syndrome.

Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society
2019

Immune Dysregulation, Polyendocrinopathy, Enteropathy, X-Linked Syndrome Associated With a Novel Mutation of FOXP3 Gene.

Frontiers in pediatrics
2019

A Mutation in the Transcription Factor Foxp3 Drives T Helper 2 Effector Function in Regulatory T Cells.

Immunity
2019

Lentiviral Gene Therapy in HSCs Restores Lineage-Specific Foxp3 Expression and Suppresses Autoimmunity in a Mouse Model of IPEX Syndrome.

Cell stem cell
2018

Clinical Heterogeneity of Immune Dysregulation, Polyendocrinopathy, Enteropathy, X-Linked Syndrome: A French Multicenter Retrospective Study.

Clinical and translational gastroenterology
2018

Hypogammaglobulinemia with decreased class-switched B-cells and dysregulated T-follicular-helper cells in IPEX syndrome.

Clinical immunology (Orlando, Fla.)
2018

Regulatory T-cell deficiency and autoimmune skin disease: Beyond the scurfy mouse and immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome.

The Journal of allergy and clinical immunology
2018

[Immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome in two cases].

Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics
2018

Role of human forkhead box P3 in early thymic maturation and peripheral T-cell homeostasis.

The Journal of allergy and clinical immunology
2018

Regulatory T-cell dysfunction induces autoantibodies to bullous pemphigoid antigens in mice and human subjects.

The Journal of allergy and clinical immunology
2018

IPEX due to an exon 7 skipping FOXP3 mutation with autoimmune diabetes mellitus cured by selective TReg cell engraftment.

Clinical immunology (Orlando, Fla.)
2018

Autoimmune Polyendocrine Syndromes.

The New England journal of medicine
2018

Somatic and germline FOXP3 mosaicism in the mother of a boy with IPEX syndrome.

European journal of immunology
2017

Atypical Late-Onset Immune Dysregulation, Polyendocrinopathy, Enteropathy, X-Linked Syndrome with Intractable Diarrhea: A Case Report.

Frontiers in pediatrics
2018

Long-term follow-up of IPEX syndrome patients after different therapeutic strategies: An international multicenter retrospective study.

The Journal of allergy and clinical immunology
2018

FOXP3 mutations causing early-onset insulin-requiring diabetes but without other features of immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome.

Pediatric diabetes
2017

DOCK8 Deficiency Presenting as an IPEX-Like Disorder.

Journal of clinical immunology
2018

Prenatal Bowel Findings in Male Siblings With a Confirmed FOXP3 Mutation.

Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine
2017

Curcumin attenuates the scurfy-induced immune disorder, a model of IPEX syndrome, with inhibiting Th1/Th2/Th17 responses in mice.

Phytomedicine : international journal of phytotherapy and phytopharmacology
2017

Whole genome sequencing identifies etiology of recurrent male intrauterine fetal death.

Prenatal diagnosis
2017

Analyses of a Mutant Foxp3 Allele Reveal BATF as a Critical Transcription Factor in the Differentiation and Accumulation of Tissue Regulatory T Cells.

Immunity
2017

Lichenoid Dermatitis in an Adult with Immune Dysregulation, Polyendocrinopathy, Enteropathy, X-Linked (IPEX) Syndrome.

Skinmed
2017

PLA2R-positive (primary) membranous nephropathy in a child with IPEX syndrome.

Pediatric nephrology (Berlin, Germany)
2017

Persistent Enteropathy in a Toddler with a Novel FOXP3 Mutation and Normal FOXP3 Protein Expression.

The Journal of pediatrics
2017

Novel pathogenic variants in FOXP3 in fetuses with echogenic bowel and skin desquamation identified by ultrasound.

American journal of medical genetics. Part A
2016

The plethora, clinical manifestations and treatment options of autoimmunity in patients with primary immunodeficiency.

Turk pediatri arsivi
2017

Mycobacterium genavense-induced spindle cell pseudotumor in a pediatric hematopoietic stem cell transplant recipient: Case report and review of the literature.

Transplant infectious disease : an official journal of the Transplantation Society
2017

Nonclassic Inflammatory Bowel Disease in Young Infants: Immune Dysregulation, Polyendocrinopathy, Enteropathy, X-Linked Syndrome, and Other Disorders.

Pediatric clinics of North America
2016

Extremely Early Onset IPEX Syndrome Caused by a Novel Small Exonic Deletion in FOXP3.

Journal of pediatric gastroenterology and nutrition
2017

Deficiency in Mucosa-associated Lymphoid Tissue Lymphoma Translocation 1: A Novel Cause of IPEX-Like Syndrome.

Journal of pediatric gastroenterology and nutrition
2016

T Regulatory Cell Biology in Health and Disease.

Current allergy and asthma reports
2018

From IPEX syndrome to FOXP3 mutation: a lesson on immune dysregulation.

Annals of the New York Academy of Sciences
2016

Quantitative analysis of tissue inflammation and responses to treatment in immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome, and review of literature.

Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi
2016

Clinical and structural impact of mutations affecting the residue Phe367 of FOXP3 in patients with IPEX syndrome.

Clinical immunology (Orlando, Fla.)
2016

Immune Dysregulation Syndromes (IPEX, CD27 Deficiency, and Others): Always Doomed from the Start?

Journal of clinical immunology
2016

A challenging undertaking: Stem cell transplantation for immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) syndrome.

The Journal of allergy and clinical immunology
2015

The autoimmune conundrum in common variable immunodeficiency disorders.

Current opinion in allergy and clinical immunology
2015

The immunological and genetic basis of immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome.

Current opinion in allergy and clinical immunology
2016

Identification of a novel nonsense mutation in the FOXP3 gene in a fetus with hydrops--Expanding the phenotype of IPEX syndrome.

American journal of medical genetics. Part A
2015

[Difference in target antigens between central tolerance and peripheral tolerance deficiencies].

Nihon Rinsho Men'eki Gakkai kaishi = Japanese journal of clinical immunology
2015

Immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome and recurrent intrauterine fetal death.

Lancet (London, England)
2015

Long-term disease course in a patient with severe neonatal IPEX syndrome.

Clinics and research in hepatology and gastroenterology
2015

Immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome associated with neonatal epidermolysis bullosa acquisita.

Pediatric dermatology
2015

Familial IPEX syndrome: different glomerulopathy in two siblings.

Pediatrics international : official journal of the Japan Pediatric Society

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Síndrome de imunodesregulação-poliendocrinopatia-enteropatia ligada ao X.

É de uma associação que acompanha esta doença? Fale com a gente →

Comunidades

Grupos ativos de quem convive com esta doença aqui no Raras

Ainda não existe comunidade no Raras para Síndrome de imunodesregulação-poliendocrinopatia-enteropatia ligada ao X

Pacientes, familiares e cuidadores se organizam em comunidades pra compartilhar experiências, fazer perguntas e se apoiar. Você pode ser o primeiro.

Tire suas dúvidas

Perguntas, dicas e experiências compartilhadas aqui na página

Participe da discussão

Faça login para postar dúvidas, compartilhar experiências e interagir com especialistas.

Fazer login

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Referências e fontes

Bases de dados externas citadas neste artigo

Publicações científicas

Artigos indexados no PubMed ligados a esta doença no grafo RarasNet — título, periódico e PMID direto da fonte, sem intermediação de IA.

  1. Pediatric IPEX-Associated Dermatitis Responds To Dupilumab: Evidence from Skin Transcriptomics and Immune Profiling.
    Journal of clinical immunology· 2026· PMID 41653277mais citado
  2. Decoding VEXAS syndrome: emerging insights into pathogenesis and clinical management.
    Current opinion in rheumatology· 2026· PMID 41175032mais citado
  3. [Immuno'logical (The scientific updates you wouldn't dare to read anywhere else): The hidden face of VEXAS syndrome].
    La Revue de medecine interne· 2026· PMID 40945967mais citado
  4. Autoimmune polyendocrine syndrome type 2 in children: a case report and literature review.
    BMC pediatrics· 2025· PMID 40316945mais citado
  5. Neutrophils take center stage in VEXAS syndrome pathogenesis.
    The Journal of clinical investigation· 2025· PMID 41178709mais citado
  6. X-Linked Immunodeficiency.
    · 2026· PMID 32965853recente
  7. Atopic dermatitis in inborn errors of immunity: at the interface of immunodeficiency and immune dysregulation.
    Immunol Res· 2025· PMID 41111099recente
  8. Case report: anti-IL-6 autoantibodies in a patient with immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome.
    Front Immunol· 2025· PMID 40977713recente
  9. Diagnostic dilemma in infantile refractory diarrhea: a rare case of IPEX syndrome.
    Med J Armed Forces India· 2024· PMID 39990538recente

Bases de dados e fontes oficiais

Identificadores e referências canônicas usadas para montar este verbete.

  1. ORPHA:37042(Orphanet)
  2. OMIM OMIM:304790(OMIM)
  3. MONDO:0010580(MONDO)
  4. GARD:1850(GARD (NIH))
  5. Variantes catalogadas(ClinVar)
  6. Busca completa no PubMed(PubMed)
  7. Q3508566(Wikidata)

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Síndrome de imunodesregulação-poliendocrinopatia-enteropatia ligada ao X
Compêndio · Raras BR

Síndrome de imunodesregulação-poliendocrinopatia-enteropatia ligada ao X

ORPHA:37042 · MONDO:0010580
Prevalência
<1 / 1 000 000
Casos
195 casos conhecidos
Herança
X-linked recessive
CID-10
E31.0 · Insuficiência poliglandular auto-imune
CID-11
Ensaios
2 ativos
Início
Infancy, Neonatal
Prevalência
0.0 (Worldwide)
MedGen
UMLS
C0342288
EuropePMC
Wikidata
Papers 10a
DiscussaoAtiva

Nenhuma novidade ainda. O agente esta monitorando.

0membros
0novidades